Question 1

Who is Reproductive Solutions (RSI)?

Accepted Answer

RSI develops evidence-based, innovative reproductive technologies designed to improve clinical outcomes while supporting both patients and providers. Our solutions focus on sperm protection, collection, and selection—reducing specimen handling risks, improving gamete quality, and enhancing workflow efficiency for clinics and laboratories.

Question 2

What are RSI’s Core Values?

Accepted Answer

People First. We prioritize the well-being and experience of patients, customers, and employees, recognizing that people are the foundation of everything we do.

Act with Integrity. We are honest, accountable, and transparent. We do what’s right, even when it’s hard.

Care for Each Other. We foster a supportive and respectful culture where empathy,  collaboration and inclusion thrive.

Deliver with Quality. We are committed to excellence in every detail, ensuring the highest standards in our products, services, and actions.

Science-Led Innovation. We lead with evidence. By turning research into real-world  solutions, we’re reshaping what’s possible in fertility care.

Always Learn and Improve. We embrace curiosity, seek feedback, and continuously evolve to meet new challenges and opportunities.

Question 3

What is ProteX™?

Accepted Answer

ProteX™ is a patented sperm collection device engineered to maintain specimen viability during and after collection. When used with media, it preserves motility for up to 24 hours, enabling flexible scheduling and reducing the urgency of immediate processing.

Question 4

How does ProteX™ benefit the clinic/lab?

Accepted Answer

• Extends specimen stability up to 24 hours with media, allowing greater flexibility in collection and processing schedules. 
 • Reduces loss of motility associated with delayed processing or suboptimal transport conditions. 
 • Facilitates at-home collection without compromising specimen integrity. 
 • Compatible with direct in-cup processing when paired with NovoSort®.

Question 5

Is ProteX™ validated?

Accepted Answer

Yes. ProteX™ is FDA-listed, undergoes biocompatibility and toxicity testing, and has been validated in clinical settings.

Question 6

How does the ProteX™ At-Home Collection work for clinical use?

Accepted Answer

At-Home Collections are shipped directly to patients and include all required components for either media-assisted (24-hour viability) or non-media (1–2 hour viability) collection. Detailed instructions and labeling are included to streamline accessioning upon arrival at the laboratory.

Question 7

What are the clinical advantages of media-assisted kits?

Accepted Answer

• Reduces scheduling constraints for patients traveling long distances. 
 • Minimizes urgency of immediate sample drop-off. 
 • Allows for flexibility in IVF cycle coordination and IUI planning.

Question 8

What is NovoSort®?

Accepted Answer

NovoSort® is a passive, non-centrifugation sperm selection system designed to enrich for progressively motile, morphologically normal sperm directly within the ProteX™ collection cup.

Question 9

What clinical advantages does NovoSort® provide?

Accepted Answer

• Gentle on sperm: Eliminates centrifugation-related ROS generation and mechanical stress. 
 • Workflow efficiency: Allows collection-to-selection in a single vessel, reducing sample transfers and contamination risk. 
 • Improved specimen quality: Enriches for sperm with higher motility and lower DNA fragmentation. 
 • Versatility: Suitable for IUI and ICSI applications using fresh ejaculated sperm with progressive motility.

Question 10

Are there use limitations?

Accepted Answer

Yes. NovoSort® is indicated for fresh ejaculated samples with progressively motile sperm. It is not validated for surgically retrieved or non-motile specimens. For frozen samples, contact RSI for separate handling protocols.

Question 11

How can ProteX™ and NovoSort® be integrated into our workflow?

Accepted Answer

Both devices are designed for easy adoption without major equipment changes. Our clinical support team can assist with: 
 • Staff training and competency documentation. 
 • Workflow adaptation and SOP development. 
 • Troubleshooting and ongoing technical support.

Question 12

What compliance and safety standards do these products meet?

Accepted Answer

RSI Technology Group’s is operating under ISO 13485:2016–quality management system  regulations, and produced in compliance with FDA 21 CFR Part 820 (Quality System Regulation). All products undergo validated sterilization and sperm survival testing to ensure safety, quality, and performance before release.

Question 13

How can I order or request samples?

Accepted Answer

You can find our products directly on our website for order, or on IVFStore.com. Contact your RSI account representative or email  support@reproductive.solutions (mailto:support@reproductive.solutions) for a sample request.

Frequently Asked
Questions

Your Questions, Clearly Answered

Have Different Questions?

COMPANY

QUICK LINK

Frequently Asked Questions

Your Questions, Clearly Answered

Have Different Questions?

COMPANY

QUICK LINK

Frequently Asked
Questions